The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-6-(4-Methylpiperazin-1-yl)-2-(1,3,6-trimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione ID: ALA4072812
PubChem CID: 130471724
Max Phase: Preclinical
Molecular Formula: C27H27N5O3
Molecular Weight: 469.55
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc2c(cc1N1C(=O)c3cccc4c(N5CCN(C)CC5)ccc(c34)C1=O)n(C)c(=O)n2C
Standard InChI: InChI=1S/C27H27N5O3/c1-16-14-22-23(30(4)27(35)29(22)3)15-21(16)32-25(33)18-7-5-6-17-20(31-12-10-28(2)11-13-31)9-8-19(24(17)18)26(32)34/h5-9,14-15H,10-13H2,1-4H3
Standard InChI Key: OFZUZFZNFMUNAS-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 40 0 0 0 0 0 0 0 0999 V2000
35.2413 -18.7922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6685 -18.7886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9531 -18.3794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2401 -19.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5272 -20.0321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5280 -20.8574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2475 -21.2683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9549 -20.0325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9550 -20.8503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6594 -21.2570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3684 -20.8502 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.3683 -20.0323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6593 -19.6212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0788 -21.2631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0764 -22.0892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7896 -22.5025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7903 -20.8520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5039 -21.2617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5086 -22.0905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2984 -22.3424 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.7820 -21.6690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2909 -21.0012 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.0832 -19.6205 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.6584 -22.0820 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.5415 -20.2151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5576 -23.1256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6070 -21.6644 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.3610 -22.5001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8123 -19.6203 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.8168 -18.7931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1061 -18.3813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3896 -18.7910 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.3884 -19.6170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1037 -20.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6762 -18.3765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 4 2 0
13 2 1 0
2 3 2 0
3 1 1 0
8 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 9 2 0
8 9 1 0
8 13 2 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
14 15 2 0
15 16 1 0
16 19 2 0
18 17 2 0
17 14 1 0
11 14 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
12 23 2 0
10 24 2 0
22 25 1 0
20 26 1 0
21 27 2 0
15 28 1 0
5 29 1 0
29 30 1 0
29 34 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
32 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 469.55Molecular Weight (Monoisotopic): 469.2114AlogP: 2.89#Rotatable Bonds: 2Polar Surface Area: 70.79Molecular Species: NEUTRALHBA: 7HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.85CX LogP: 3.30CX LogD: 2.71Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.42Np Likeness Score: -1.05
References 1. Bouché L, Christ CD, Siegel S, Fernández-Montalván AE, Holton SJ, Fedorov O, Ter Laak A, Sugawara T, Stöckigt D, Tallant C, Bennett J, Monteiro O, Díaz-Sáez L, Siejka P, Meier J, Pütter V, Weiske J, Müller S, Huber KVM, Hartung IV, Haendler B.. (2017) Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains., 60 (9): [PMID:28402630 ] [10.1021/acs.jmedchem.7b00306 ]